Integration of Artificial Intelligence in Drug Safety
Artificial intelligence is revolutionizing the Pharmacovigilance Market trends by automating routine processes and improving signal detection. AI algorithms are being deployed to handle massive volumes of individual case safety reports (ICSRs), reducing manual workload and improving accuracy.
Machine learning models can also identify subtle patterns in safety data that traditional methods may miss, accelerating risk assessment. Natural language processing further enhances the ability to analyze unstructured data, such as patient narratives or literature.
The result is faster, more accurate pharmacovigilance workflows. Companies that integrate AI are positioning themselves ahead of competitors, not only improving compliance but also reducing operational costs significantly.